DAMIAN J. TROISE

Valeant cutting ties with Philidor

NEW YORK (AP) — Valeant Pharmaceuticals, a company that has come under intense scrutiny for its drug prices, has cut ties with Philidor following accusations...

Roche starts hostile bid for Genentech

Swiss drugmaker Roche surprised Wall Street with plans for a lower-than-expected and hostile $42.1 billion buyout offer for Genentech on Friday, a move some consider...